SCHEMBL26575

SCHEMBL26575

[CH2]c1ccc(O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28500667 0.96 — —
SCHEMBL3727100 0.90 ESR1 (0.69) —
SCHEMBL1456756 0.83 MEN1 (0.74) —
Hydroquinone SCHEMBL18095025 0.79 HSD17B10 (0.80) —
Hydroquinone SCHEMBL15516 0.78 — —
SCHEMBL147275 0.78 — —
Hydroquinone SCHEMBL460669 0.78 ALOX15 (1.00) —
Hydroquinone SCHEMBL11511669 0.78 ALOX15 (1.00) —
Hydroquinone SCHEMBL730505 0.75 MAPT (0.73) —
Hydroquinone SCHEMBL11222941 0.75 MAPT (0.73) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 13835 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118359514-A N-ester salicylamide compound and preparation method and application thereof 湖南科技大学 2024-07-19 — — CN claimed
WO-2024151843-A1 TARGETED UNIVERSAL DELIVERY SYSTEM OF DON AND OTHER DRUGS THE JOHNS HOPKINS UNIVERSITY (US) 2024-07-18 — — WO claimed
CN-118344278-A Rosin amino acid compound and preparation method and application thereof 广西中医药大学 2024-07-16 — — CN claimed
US-20240226313-A1 CEACAM5 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF SEAGEN INC. 2024-07-11 — — US claimed
CN-118307501-A Dihydrophenanthropyrrole compound, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2024-07-09 — — CN claimed
US-20240218022-A1 ANTI-VISTA MACROCYCLIC PEPTIDES AND COMPOSITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-07-04 — — US claimed
US-20240216420-A1 HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF SEAGEN INC (US) 2024-07-04 — — US claimed
CN-115785655-B Super-black weather-resistant polyamide material and preparation method and application thereof 上海中镭新材料科技有限公司 2024-07-02 — — CN claimed
US-20240207253-A1 Inhibitors of CDR1 for Reversal of Azole Drug Resistance in Fungal Infections THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2024-06-27 — — US claimed
US-20240197666-A1 DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC) K-GEN THERAPEUTICS, INC. (US) 2024-06-20 — — US claimed
US-4072576-A Method for studying enzymatic and other biochemical reactions AB KABI (SW) 1978-02-07 — — US claimed
US-4060687-A Cephalosporins having a 3-α substituted alkyl grouping MERCK & CO., INC. (US) 1977-11-29 — — US claimed
US-4041041-A FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS MERRELL TORAUDE ET COMPAGNIE (FR) 1977-08-09 — — US claimed
US-4039549-A INHIBITS CNS TRANSMITTERS MERRELL TORAUDE ET COMPAGNIE (FR) 1977-08-02 — — US claimed
US-4010153-A Preparation of chiral 1,4-benzodiazepin-2-one-derivatives by reaction of (s)-α-amino acid chloride hydrochlorides etc. CRC COMPAGNIA DI RICERCA CHIMICA S.A. (CH) 1977-03-01 — — US claimed
US-3987040-A 3-SUBSTITUTED METHYL-7-ACYLAMINO-7-METHOXY-2-CEPHEM-4-CARBOXYLIC ACID AND ITS ESTERS MERCK & CO., INC. (US) 1976-10-19 — — US claimed
US-3980729-A PHENOLIC PREPOLYMER, SILANOL-CONDENSATION CATALYST AND A CURING CATALYST SHIN-ETSU CHEMICAL COMPANY LIMITED (JA) 1976-09-14 — — US claimed
US-3960927-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS RICHARDSON-MERRELL INC. (US) 1976-06-01 — — US claimed
US-3959356-A PHARMACOLOGY RICHARDSON-MERRELL INC. (US) 1976-05-25 — — US claimed
US-3934027-A 18β-Glycyrrhetinic acid amides useful as antiulcer agents PFIZER INC. (US) 1976-01-20 — — US claimed
Send feedback